Literature DB >> 8787898

Susceptibilities of bovine summer mastitis bacteria to antimicrobial agents.

H Jousimies-Somer1, S Pyörälä, A Kanervo.   

Abstract

The susceptibility to 9 antimicrobial agents of 32 aerobic bacterial isolates and to 10 antimicrobial agents of 37 anaerobic bacterial isolates from 23 cases of bovine summer mastitis (16 Actinomyces pyogenes isolates, 8 Streptococcus dysgalactiae isolates, 3 S. uberis isolates, 3 S. acidominimus isolates, 2 Streptococcus spp., 15 Peptostreptococcus indolicus isolates, 10 Fusobacterium necrophorum isolates, and 12 isolates of anaerobic gram-negative rods) was determined by the agar dilution method. All isolates except one Bacteroides fragilis isolate (beta-lactamase producer) were susceptible to penicillin G, amoxicillin, amoxicillin-clavulanate, cefoxitin, clindamycin, and chloramphenicol (the B. fragilis strain was susceptible to the last four), which had MICs at which 90% of isolates were inhibited (MIC90s) of < or = 0.06, < or = 0.06, < or = 0.06 0.25, < or = 0.06, and 4.0 micrograms/ml, respectively. Spiramycin was active against the gram-positive aerobes (MIC90, 1.0 microgram/ml) but not against the anaerobes (MIC90, 16.0 micrograms/ml). Similar trends were noted for susceptibilities of aerobic and anaerobic bacteria to ofloxacin (MIC90s, 2.0 and 8 micrograms/ml, respectively). Occasional strains of aerobic streptococci were resistant to oxytetracycline, but all anaerobes were susceptible. Tinidazole was active against all anaerobes (MIC90, 2.0 micrograms/ml). beta-Lactamase was produced only by the B. fragilis isolate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787898      PMCID: PMC163075     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Penicillin G and penicillin G-tinidazole treatment of experimentally induced summer mastitis--effect on elimination rates of bacteria and outcome of the disease.

Authors:  J Hirvonen; S Pyörälä; A Heinäsuo; H Jousimies-Somer
Journal:  Vet Microbiol       Date:  1994-12       Impact factor: 3.293

2.  In-vitro antimicrobial susceptibility of Bacteroides and Fusobacterium isolated from footrot in goats.

Authors:  S Piriz Duran; J Valle Manzano; R Cuenca Valera; S Vadillo Machota
Journal:  Br Vet J       Date:  1990 Sep-Oct

3.  Susceptibilities of anaerobic bacteria isolated from animals with ovine foot rot to 28 antimicrobial agents.

Authors:  S Piriz; R Cuenca; J Valle; S Vadillo
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Pharmacokinetics of spiramycin after intravenous, intramuscular and subcutaneous administration in lactating cows.

Authors:  P Sanders; G Moulin; P Guillot; M Dagorn; P Perjant; B Delepine; C Gaudiche; D Mourot
Journal:  J Vet Pharmacol Ther       Date:  1992-03       Impact factor: 1.786

5.  Pharmacokinetics of cephalexin glycinate in lactating cows and ewes.

Authors:  S Soback; G Ziv; A Bor; M Shapira
Journal:  Zentralbl Veterinarmed A       Date:  1988-12

6.  Clinical, bacteriological and therapeutic aspects of bovine mastitis caused by aerobic and anaerobic pathogens.

Authors:  S Pyörälä; H Jousimies-Somer; M Mero
Journal:  Br Vet J       Date:  1992 Jan-Feb

7.  Comparative pharmacokinetics, bioavailability and renal clearance of five parenteral oxytetracycline-20% formulations in dairy cows.

Authors:  D J Mevius; J F Nouws; H J Breukink; T B Vree; F Driessens; R Verkaik
Journal:  Vet Q       Date:  1986-10       Impact factor: 3.320

8.  The identification and antimicrobial susceptibility of anaerobic bacteria from pneumonic cattle lungs.

Authors:  J M Chirino-Trejo; J F Prescott
Journal:  Can J Comp Med       Date:  1983-07

9.  Concentrations of penicillin, streptomycin, and spiramycin in bovine udder tissue liquids.

Authors:  A Franklin; M Horn af Rantzien; N Obel; K Ostensson; G Aström
Journal:  Am J Vet Res       Date:  1986-04       Impact factor: 1.156

10.  Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.

Authors:  E J Goldstein; C A Nesbit; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.